NCT06724822View on ClinicalTrials.gov

RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

NAEnrolling by invitationINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

October 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

RF Vapor Ablation

RF Vapor ablation of the duodenum

Trial Locations (1)

Unknown

Clinica Colonial, Santiago

Sponsors

Lead Sponsor

Aqua Medical, Inc.
All Listed Sponsors
lead

Aqua Medical, Inc.

INDUSTRY

NCT06724822 - RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter